Benjamin Hohl – Insider Trading Activity | DataHeimdall

Benjamin Hohl

CHIEF FINANCIAL OFFICER at Enliven Therapeutics, Inc.

CIK: 1672619

15

Total trades

0

Buys

10

Sells

Dec 27, 2024

Last trade

Date	Stock	Type	Shares	Value	Src
Dec 27, 2024	ELVNEnliven Therapeutics, Inc.	Option	3,350	$8K
Dec 27, 2024	ELVNEnliven Therapeutics, Inc.	Sell	900	$20K
Dec 27, 2024	ELVNEnliven Therapeutics, Inc.	Option	900	$2K
Dec 27, 2024	ELVNEnliven Therapeutics, Inc.	Sell	3,350	$74K
Dec 26, 2023	ELVNEnliven Therapeutics, Inc.	Sell	12,000	$176K
Dec 26, 2023	ELVNEnliven Therapeutics, Inc.	Option	12,000	$13K
Dec 22, 2023	ELVNEnliven Therapeutics, Inc.	Option	1,030	$3K
Dec 22, 2023	ELVNEnliven Therapeutics, Inc.	Sell	1,030	$16K
Dec 22, 2023	ELVNEnliven Therapeutics, Inc.	Sell	100	$2K
Dec 22, 2023	ELVNEnliven Therapeutics, Inc.	Option	100	$248
Dec 22, 2023	ELVNEnliven Therapeutics, Inc.	Sell	983	$15K
Dec 22, 2023	ELVNEnliven Therapeutics, Inc.	Sell	102	$2K
Dec 30, 2022	IMRAIMARA Inc.	Sell	20,000	$81K
Dec 28, 2022	IMRAIMARA Inc.	Sell	19,843	$80K
Dec 28, 2022	IMRAIMARA Inc.	Sell	157	$634.28